FDA · Feed

Biologics

21 signals · sorted by published date

Biologics/Update
· 3h ago
Consumer Updates
FDA Vaccines, Blood & Biologics
Medium
Biologics/Update
· 3h ago
Drugs@FDA Data Files
FDA Center for Biologics Evaluation and Research (CBER)
Medium
Biologics/Update
· 4h ago
What’s New for Biologics
N/A - Source provides limited detail
Low
Biologics/Update
· 4h ago
Is It Really 'FDA Approved'?
FDA Vaccines, Blood & Biologics
Medium
Biologics/Update
· 4h ago
Regulatory Education for Industry (REdI) Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products - 05/19/2026
Drug manufacturers, Device manufacturers
Medium
Biologics/Update
· 2d ago
Artificial Intelligence for Drug Development
Sponsors utilizing AI/ML tools in drug development
Medium
Biologics/Update
· 2d ago
2026 Biological License Application Approvals
Source does not list specific companies
Medium
Biologics/Update
· 3d ago
OTP Events, Meetings, and Workshops
FDA Vaccines, Blood & Biologics
Medium
Biologics/Update
· 3d ago
Patient Listening Session Summaries
Manufacturers of biologic therapies
Medium
Biologics/Update
· 3d ago
Public Webinar: FDA Review of Biologics License Applications for Blood and Source Plasma - 05/12/2026
Blood Establishments, Source Plasma Manufacturers
Medium
Biologics/Update
· 4d ago
Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement - 03/12/2026
Influenza Vaccine Manufacturers
Medium
Biologics/Update
· 4d ago
OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products - 06/04/2026
FDA Vaccines, Blood & Biologics
Medium
Biologics/Update
· 4d ago
GAMUNEX-C
Grifols Therapeutics LLC
Medium
Biologics/Update
· 5d ago
Biologics Electronic Reading Room (eFOIA)
FDA Vaccines, Blood & Biologics
Low
Biologics/Update
· 5d ago
Commissioner's National Priority Voucher (CNPV) Pilot Program
FDA Vaccines, Blood & Biologics
High
Biologics/Update
· 6d ago
Labeling and Promotion Guidances
FDA Vaccines, Blood & Biologics
Medium
Biologics/Update
· 6d ago
Devices Guidances
CBER-regulated entities
Low
Biologics/Update
· 6d ago
CMC and GMP Guidances
FDA Vaccines, Blood & Biologics
Medium
Biologics/Press Release
· 1w ago
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program
Not specified in source excerpt
High
Biologics/Guidance
· 2w ago
FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development
Sponsors of human gene therapy products
High
Biologics/Approval
· Mar 26, 2026
FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
Rocket Pharmaceuticals
High